Dx&Vx said it succeeded in raising 17.8 billion won ($12.9 million) by issuing convertible bonds (CB).According to the company, it will use the new fund for operating use and acquiring shares of other corporations. DA 1st Company Limited, a special purpose company, will acquire all CBs.The maturity
It has become almost certain that the government would cancel the licenses of all brain function-improving drugs using acetyl-L-carnitine as the main ingredient.Faced with a crisis of losing the annual 50 billion won (36.2 million) prescription market, domestic drugmakers called for the Ministry of
Mathematicians predicted that the number of new confirmed Covid-19 cases per day will drop to 50,000 in two weeks as the pandemic resurgence has turned into a declining phase.According to a report from the Covid-19 mathematical modeling task force, an Ulsan National Institute of Science and Technolo
A year has passed since Organon & Co. spun off from MSD, vowing to be a company specializing in the field of female healthcare.Over the past year, Organon has made positive efforts to promote female health. For instance, it acquired companies producing postpartum solutions to treat postpartum hyster
Global Bio Conference (GBC) 2022 ended its three-day run on Wednesday.According to the conference organizers, the GBC, hosted by the Ministry of Food and Drug Safety (MFDS), aims to set the stage for active communication aiming to lead a balanced international regulatory environment.The conference p
Korea recently scrapped requiring a Covid-19 test for inbound travelers before entry to the nation but kept the mandatory PCR test within 24 hours after arrival in Korea.However, the government is poorly monitoring mandatory PCR tests among entrants, a lawmaker said Thursday.Rep. In Jae-keun of the
A research team at Ajou University School of Medicine said a decrease in mitochondrial matrix caseinolytic protease P (ClpP) plays an important role in the pathogenesis of nonalcoholic steatohepatitis (NASH) induced by a high-fat and high-fructose diet.ClpP regulates the protein balance in mitochond
Yuyu Pharmaceutical said it launched Senuvela, a treatment for hyperphosphatemia containing Sevelamer.Senuvela can control serum phosphorus in patients with chronic kidney disease (CKD) who do not have sufficient phosphorus excretion through diet and dialysis alone.With the launch of Senuvela, Yuyu
Patients with amyloid-negative amnestic mild cognitive impairment (MCI) may be at risk of progressing to dementia even if they had subthreshold levels of amyloid deposition, a Korean study showed.The research team, led by Professor Kim Hyung-ji at the Department of Neurology of Euijeongbu Eulji Medi
Hanmi Pharm and Seoul National University (SNU) have decided to collaborate to create a hub to foster global bio-industry talents. Hanmi said the company and SNU signed a memorandum of understanding to cooperate on building a global hub to cultivate a bio workforce as part of the World Health Organi
Daewoong Pharmaceutical has won the approval for a phase 2 investigational new drug (IND) clinical trial of DWN12088, its treatment candidate for idiopathic pulmonary fibrosis (IPF), in Korea following the nod in the U.S.The Ministry of Food and Drug Safety gave the go-ahead to Daewoong’s treatment
The government will operate a total of 6,000 one-stop medical institutions during the Chuseok holiday and at least 700 one-stop medical institutions on Chuseok Day on Saturday this week, Prime Minister Han Duck-soo said during a Covid-19 response meeting on Wednesday."After we announced quarantine a
Despite the sluggish initial public offering (IPO) market continuing throughout the year, four Korean biotech companies are preparing to go public in September. The four companies are SunBio, RP Bio, Plasmapp, and Shaperon.Most biopharmaceutical companies that went public in the first half suffered
The domestic biopharmaceutical businesses’ interests in digital treatment technology were “hot” if a recent industrial fair was any guide.More than 100 industry officials from biopharmaceutical companies, medical institutions, and the digital healthcare sector participated in the “Digital Healthcare
Allergan Aesthetics Korea said it has identified four key themes that will drive consumer behavior change in the global aesthetics market. The four key themes are beauty empowerment, aesthetic fluency, untabooing treatments, and a desire to move back to nature.The company has published the four them
Boryung said it obtained local marketing approval for finasteride-containing spray treatment for hair loss. Attention is on whether the new product could enlarge its presence in the hair loss treatment market dominated by MSD’s Propecia tablet. On Tuesday, the Ministry of Food and Drug Safety author
The European Medicines Agency (EMA) refused a rolling review of SK Bioscience’s Covid-19 vaccine, SKYCovine, due to “changing pandemic conditions,” a senior official at SK Bioscience said.A rolling review speeds up the evaluation of a drug or a vaccine during a public health crisis.The SK Bioscience
Myongji Hospital said it started securing medical competitiveness in the post-Covid-19 era by installing new medical equipment worth about 30 billion won ($21.6 million).Starting with the Somatom Force, a dual 576 slice computed tomography (CT), on Tuesday, the hospital plans to introduce various me
Quarantine authorities are preparing countermeasures based on the high probability of a "twindemic" situation -- the dual threat of a severe flu outbreak on top of the Covid-19 pandemic -- in the fall and winter of this year."There is a high possibility of simultaneous outbreaks of Covid-19 and infl
The growth of Alvogen Korea's obesity treatment Qsymia, which had been competing for a top market share with Novo Nordisk's Saxenda, is slowing down.Industry watchers attribute the relatively weaker performance of Qsymia to the absence of indications for obese adolescents aged 12 or older.Saxenda ob